loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 209606 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ENASIDENIB MESYLATE (2)

filter

01 BRISTOL MYERS SQUIBB (2)

filter

01 TABLET;ORAL (2)

filter

01 EQ 100MG BASE (1)

02 EQ 50MG BASE (1)

filter

01 USA (2)

URL Supplier Web Content
TABLET;ORAL
EQ 100MG BASE
IDHIFA
USA
209606
2017-08-01
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
EQ 50MG BASE
IDHIFA
USA
209606
2017-08-01
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 209606

Looking for CTD TGA MCC DOSSIER APPLICATION 209606 2

19

Bristol Myers Squibb, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is ENASIDENIB MESYLATE, with a corresponding application number 209606 and regulatory information .

proudly manufactured in the

approval since 2017-08-01

Bristol Myers Squibb's IDHIFA TABLET;ORAL, medication with EQ 100MG BASE of ENASIDENIB MESYLATE.

18

Bristol Myers Squibb, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is ENASIDENIB MESYLATE, with a corresponding application number 209606 and regulatory information .

proudly manufactured in the

approval since 2017-08-01

Bristol Myers Squibb's IDHIFA TABLET;ORAL, medication with EQ 50MG BASE of ENASIDENIB MESYLATE.

Post Enquiry
POST ENQUIRY